Overview

Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
A-007 is an investigational therapy which may be effective in the treatment of pre-cancerous cervical dysplasia (abnormal cell growth). The purpose of this study is to evaluate the safety and efficacy of A-007, when used to treat high-grade cervical dysplasia.
Phase:
Phase 2
Details
Lead Sponsor:
Tigris Pharmaceuticals